News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xizang Haisco Pharma Completes $127 Million IPO


1/17/2012 11:02:30 AM

January 17, 2012 -- Xizang Haisco Pharmaceutical Group, which produces TCM drug formulations and active pharmaceutical ingredients, completed a $127 million IPO on Shenzhen’s Small and Medium-Sized Enterprises Board. The company, located in China’s autonomous Tibet region, is the 11th Tibetan entity to become publicly owned. CITIC Securities was the lead underwriter. More details....

Stock Symbol: (SHE: 002653)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES